Burford Capital (BUR) investor relations material

Executive summary

• New business surged with a 39% year-over-year increase in definitive commitments, reaching $872 million, and a 20% portfolio base growth, supporting long-term goals to double the business by 2030.

• Portfolio modeled realizations rose by $700 million to $5.2 billion at year-end 2025, indicating strong future cash generation potential.

• Realizations remained robust with 69 assets generating proceeds, but total realizations fell to $458 million from $641 million in FY24 due to fewer large case wins.

• Portfolio quality remains strong, with stable loss rates and returns, and management remains optimistic about future growth potential.

• Significant progress made in market expansion, including launches in Madrid and Seoul.

Financial highlights

• FY25 capital provision income was $331 million, down 15% from $388 million in FY24, mainly due to fewer large wins and higher unrealized losses.

• Asset management income was $36 million, down from $45 million in FY24, primarily due to lower profit-sharing from BOF-C.

• Portfolio value increased from just under $3.6 billion to $3.9 billion year-over-year.

• Cash and marketable securities increased to $621 million at year-end, after a $500 million bond issuance at 7.5% to refinance maturing debt.

• Book value per share rose to $11.18, and tangible book value per share to $10.57 at year-end.

Outlook and guidance

• Management expects continued strong new business growth and portfolio expansion, with the business well-positioned for asymmetric upside despite ongoing case duration extensions and unrealized fair value adjustments.

• No specific guidance provided for 2026 realizations due to unpredictability of litigation timelines.

• Long-term ROE target remains at 20%, with current multi-year ROE in the teens.

• YPF-related assets are expected to deliver significant recoveries, with a $16 billion judgment against Argentina under appeal and enforcement actions ongoing.

• Forward-looking statements are subject to significant risks and uncertainties, as detailed in the annual report.